Vor Bio to Participate in the Wedbush PacGrow Healthcare Conference
By:
Vor Biopharma via
GlobeNewswire
August 01, 2023 at 08:00 AM EDT
CAMBRIDGE, Mass., Aug. 01, 2023 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, will host in-person 1x1 investor meetings at the 2023 Wedbush PacGrow Healthcare Conference.
Wedbush PacGrow Healthcare Conference
1x1 Investor Meetings: August 8-9, 2023
Location: Lotte Palace Hotel, New York, NY
About Vor Bio
Vor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant. For more information, visit: www.vorbio.com.
Contact:
Media & Investors
Sarah Spencer
+1 857-242-6076
sspencer@vorbio.com
More News
View More
DoorDash’s Recent Stock Dip Equals 60% Upside ↗
November 23, 2025
Via MarketBeat
Tickers
DASH
Wall Street Loves Williams-Sonoma Right Now—Here’s Why the Stock Could Soar in 2026 ↗
November 23, 2025
Via MarketBeat
Tickers
WSM
Meta Wins FTC Fight, Keeps Instagram Growth Machine Intact ↗
November 23, 2025
Via MarketBeat
Tickers
META
Red Cups or Red Flags: Starbucks’ Bet on a Holiday Recovery ↗
November 23, 2025
Via MarketBeat
Tickers
SBUX
Recent Quotes
View More
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
>
